The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

Taiwanese scientists have discovered a new way to synthesize circular RNA (circRNA), which could be applied to vaccine ...

Moderna (NASDAQ: MRNA) became a hot investment during the pandemic as its COVID vaccine made investors bullish on its future.

Robert F Kennedy Jr has issued a 90-day pause for a $200million Biden-era contract with Vaxart Inc to develop a new oral ...

The U.S. government awarded Moderna $590 million in January to advance the development of its bird flu vaccine ...